Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1900 of 2051 entries
View as:

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00443729 Org: User:
Start: 05/31/07 End: 04/30/09 Due: 04/30/10

MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)

Phase: N/A Priority: Normal
NCT ID: NCT00289848 Org: User:
Start: 03/31/06 End: 03/31/07 Due: 03/31/08

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

Phase: N/A Priority: Normal
NCT ID: NCT03473925 Org: User:
Start: 04/10/18 End: 05/19/21 Due: 05/19/22

A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007).

Phase: N/A Priority: Normal
NCT ID: NCT06295809 Org: User:
Start: 04/18/24 End: 03/05/26 Due: 03/05/27

Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)

Phase: N/A Priority: Normal
NCT ID: NCT05507450 Org: User:
Start: 09/07/22 End: 05/07/24 Due: 05/07/25

A Study of the Pharmacokinetics of Two Formulations of MK-1006 (MK-1006-010 AM1)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00979459 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

Phase: N/A Priority: Normal
NCT ID: NCT00083967 Org: User:
Start: 06/30/04 End: 04/30/06 Due: 04/30/07

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT00005921 Org: User:
Start: - End: - Due: -

A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)

Phase: N/A Priority: Normal
NCT ID: NCT01953692 Org: User:
Start: 11/22/13 End: 06/26/20 Due: 06/26/21

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

Phase: N/A Priority: Normal
NCT ID: NCT05173987 Org: User:
Start: 02/03/22 End: 05/27/27 Due: 05/27/28

Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)

Phase: N/A Priority: Normal
NCT ID: NCT00109122 Org: User:
Start: 11/30/01 End: 07/31/06 Due: 07/31/07

Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)

Phase: N/A Priority: Normal
NCT ID: NCT01926015 Org: User:
Start: 09/19/13 End: 06/06/14 Due: 06/06/15

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Phase: N/A Priority: Normal
NCT ID: NCT06482112 Org: User:
Start: 07/29/24 End: 06/23/25 Due: 06/23/26

Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547)

Phase: N/A Priority: Normal
NCT ID: NCT01436578 Org: User:
Start: 02/29/12 End: 11/30/13 Due: 11/30/14

Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)

Phase: N/A Priority: Normal
NCT ID: NCT00954993 Org: User:
Start: 01/13/10 End: 03/04/11 Due: 03/04/12

MK0524A Phase IIb Study (0524A-011)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00536237 Org: User:
Start: 08/31/04 End: 12/31/06 Due: 12/31/07

A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)

Phase: N/A Priority: Normal
NCT ID: NCT06772779 Org: User:
Start: 04/01/24 End: 06/04/24 Due: 06/04/25

The Effect of Food and Water Volume in Healthy Adult Participants Administered Enlicitide Decanoate (MK-0616) (MK-0616-022)

Phase: N/A Priority: Normal
NCT ID: NCT06658652 Org: User:
Start: 10/24/23 End: 12/26/23 Due: 12/26/24

A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

Phase: N/A Priority: Normal
NCT ID: NCT02358031 Org: User:
Start: 03/19/15 End: 07/19/23 Due: 07/19/24

Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)

Phase: N/A Priority: Normal
NCT ID: NCT02578680 Org: User:
Start: 01/15/16 End: 06/22/23 Due: 06/22/24

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)

Phase: N/A Priority: Normal
NCT ID: NCT05425732 Org: User:
Start: 07/13/22 End: 05/18/23 Due: 05/18/24

A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)

Phase: N/A Priority: Normal
NCT ID: NCT00109135 Org: User:
Start: 01/31/05 End: 06/30/05 Due: 06/30/06

A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)

Phase: N/A Priority: Normal
NCT ID: NCT06658626 Org: User:
Start: 03/10/23 End: 08/02/23 Due: 08/02/24

A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004)

Phase: N/A Priority: Normal
NCT ID: NCT01357161 Org: User:
Start: 07/26/11 End: 08/08/16 Due: 08/08/17

A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)

Phase: N/A Priority: Normal
NCT ID: NCT01513239 Org: User:
Start: 02/01/12 End: 05/22/15 Due: 05/22/16